Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Eur Radiol. 2016 Dec 5;27(7):2903–2915. doi: 10.1007/s00330-016-4623-9

Table 2. All qualitative MR features and their associations with LMS.

Qualitative MR features Reader 1 Reader 2
ALM (N=22) N (%) LMS (N=19) N (%) p-value ALM (N=22) N (%) LMS (N=19) N (%) p-value
Pelvic fluid Absent 14 (63.6) 10 (52.6) 0.54 16 (72.7) 10 (52.6) 0.21
Present 8 (36.4) 9 (47.4) 6 (27.3) 9 (47.4)
Borders Smooth 20 (90.9) 3 (15.8) <0.0001 19 (86.4) 5 (26.3) 0.0001
Nodular 2 (9.1) 16 (84.2) 3 (13.6) 14 (73.7)
Haemorrhage Absent 18 (81.8) 1 (5.3) <0.0001 21 (95.5) 0 (0.0) <0.0001
Present 4 (18.2) 18 (94.7) 1 (4.5) 19 (100.0)
Signal intensity on T2WIa Hypointense 4 (18.2) 1 (5.3) 0.34 6 (27.3) 1 (5.3) 0.17
Isointense 11 (50.0) 8 (42.1) 10 (45.5) 10 (52.6)
Hyperintense 7 (31.8) 10 (52.6) 6 (27.3) 8 (42.1)
Heterogeneity on T2WI Homogenous 6 (27.3) 1 (5.3) 0.10 5 (22.7) 0 (0.0) 0.05
Heterogeneous 16 (72.7) 18 (94.7) 17 (77.3) 19 (100.0)
Cystic alteration(s) Absent 10 (45.5) 3 (15.8) 0.05 8 (36.4) 2 (10.5) 0.08
Present 12 (54.5) 16 (84.2) 14(63.6) 17 (89.5)
Location of cystic alteration(s) None 10 (45.5) 3 (15.8) 0.32 8 (36.4) 2 (10.5) 0.17
Peripheral 6 (27.3) 4 (21.1) 6 (27.3) 3 (15.8)
Central 2 (9.1) 6 (31.6) 1 (4.5) 5 (26.3)
Central + peripheral 4 (18.2) 6 (31.6) 7 (31.8) 9 (47.4)
Fluid-fluid level(s) Absent 21 (95.5) 16 (84.2) 0.32 21 (95.5) 16 (84.2) 0.32
Present 1 (4.5) 3 (15.8) 1 (4.5) 3 (15.8)
“T2 dark” area(s) Absent 19 (86.4) 3 (15.8) <0.0001 19 (86.4) 4 (21.1) <0.0001
Present 3 (13.6) 16 (84.2) 3 (13.6) 15 (78.9)
Flow voids Absent 8 (36.4) 0 (0.0) 0.0041 11 (50.0) 0 (0.0) 0.0002
Present 14 (63.6) 19 (100.0) 11 (50.0) 19 (100.0)
Signal intensity on contrasted imagesβ Hypointense 4 (18.2) 8 (42.1) 0.28 5 (22.7) 9 (47.4) 0.14
Isointense 15 (68.2) 10 (52.6) 15 (68.2) 10 (52.6)
Hyperintense 3 (13.6) 1 (5.3) 2 (9.1) 0 (0.0)
Heterogeneity on contrasted images Homogenous 8 (36.4) 0 (0.0) 0.0041 8 (36.4) 0 (0.0) 0.0041
Heterogeneous 14 (63.6) 19 (100.0) 14 (63.6) 19 (100.0)
Unenhanced area(s) Absent 9 (40.9) 0 (0.0) 0.0017 8 (36.4) 0 (0.0) 0.0041
Present 13 (59.1) 19 (100.0) 14 (63.6) 19 (100.0)
Location of unenhanced area(s) None or Non-central 16(72.7) 1 (5.3) <0.0001 15 (68.2) 0 (0.0) <0.0001
Central 6 (27.3) 18 (94.7) 7 (31.8) 19 (10.0)

Note: ALM atypical leiomyoma, LMS leiomyosarcoma, T2WI T2-weighted image

a

Relative to the outer myometrium

β

Relative to the myometrium